AKG supplement trial for older heart bypass patients
Part of Heart & circulation clinical trials.
This trial tests whether a supplement called alpha ketoglutarate (AKG) can help older adults recover better after heart bypass surgery. If you are 50 or older and scheduled for elective bypass surgery, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years old or older
- You are scheduled for elective coronary artery bypass graft (CABG) surgery that uses a heart-lung machine
- You are able to understand and agree to the study
- You are not already taking AKG supplements
- You do not have certain mental health conditions or an active infection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking dietary supplements before and after coronary artery bypass surgery can improve recovery and healthcare quality. It is for people aged 40-80 who are having bypass surgery.
This trial tests whether a low dose of colchicine, an anti-inflammatory medication, can help prevent bypass grafts from closing after heart surgery. You would take this medication for a set period after your coronary artery bypass graft (CABG) surgery.
This trial tests whether a supplement called nicotinamide mononucleotide (NMN) can help people recover better after heart bypass surgery. NMN is related to vitamin B3 and may protect the kidneys and heart during surgery.
This trial tests a study drug called EA-230 to see if it can help people recover faster after heart bypass surgery (CABG). If you are scheduled for a planned surgery with at least 3 bypass grafts, you may be able to join.
This trial tests whether combining two natural supplements (CoQ10 and glutathione) can protect your kidneys during heart bypass surgery. It may help prevent acute kidney injury, a common complication after these procedures.
This study tests a new way to connect a bypass graft during heart bypass surgery for people with blocked heart arteries. The goal is to see if the new graft can be safely placed and works well enough to improve outcomes compared with the standard approach.
Hear when a new CABG trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.